over 24 years of clinical trial experience
since the first HUMIRA trial in 1997.
More than 1.4 million patients worldwide
have been prescribed HUMIRA for an FDA-approved condition.*
*As of July 2020.
The resources you need, when you need them.
HUMIRA Complete is more than just a support program. It’s our promise to be there for you with the information and resources you need to start and stay on track with HUMIRA.
Our dedicated Ambassadors* are the heart of HUMIRA Complete.
Your Ambassador is there to get to know you and your treatment needs to provide you with personalized, 1-to-1 help every step of the way.
Prefer to meet virtually? Ask your Ambassador if virtual visits are available.
You can also ask your Ambassador for help connecting you with resources, such as:
Your Ambassador is always here to help you.
If you have questions or need help accessing the resources above, reach out to your Ambassador or call 1.800.4HUMIRA (1.800.448.6472).
*Nurse Ambassadors are provided by AbbVie and do not work under the direction of your health care professional (HCP) or give medical advice. They are trained to direct patients to their HCP for treatment-related advice, including further referrals.
Eligibility: Available to patients with commercial insurance coverage for HUMIRA® (adalimumab) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit HUMIRASavingsCard.com or call 1.800.4HUMIRA for additional information. To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy
Understanding a complex condition.
The more you know about ulcerative colitis (UC) and what to expect, the easier it may be to understand your condition. This can also help you explain your experience to others.
An unpredictable condition
UC varies between periods when its symptoms are active (called “flaring”), and periods when there are fewer symptoms. This may differ from person to person and change over time.
A chronic and progressive disease
UC is a chronic inflammatory bowel disease (IBD) that affects the large intestine. Chronic means symptoms may keep coming back and could last a long time.
Since UC is chronic, the inflammation that contributes to UC symptoms will likely be persistent. So once you have UC, you may always have it since there is no known cure.
While UC may begin slowly, over time, it can get worse.
INTESTINE
Where it strikes
UC can affect any part of the large intestine, including the colon, rectum, sigmoid colon, and left-descending colon.
A combination of causes
The exact cause of UC is unknown. It is believed to be caused by a combination of immune, genetic, and environmental factors.
A combination of factors.
While the cause of ulcerative colitis (UC) is unknown, there are several factors that may increase your chances of getting it. Talk to your doctor to learn more about possible risk factors.
Age
While UC can occur at any age, most people are diagnosed between the ages of 15 and 30. Others may not develop the disease until after age 60.
Family history
People are at higher risk if they have a parent, sibling, or child with the disease. Up to 20% of people with UC have a blood relative who has IBD.
The immune system/inflammation connection.
Normally the immune system protects your body by attacking disease-causing germs, including bacteria and viruses. With ulcerative colitis (UC), the immune system becomes overactive.
Immune System Overreacts
The immune system mistakenly sends white blood cells rushing to your large intestine.
Tnf-Alpha
This sets off a chain reaction causing activation of other cells and proteins involved in inflammatory response, such as tumor necrosis factor-alpha (TNF-alpha).
Inflammation
The result is chronic inflammation that can cause pain and other symptoms of UC.
How HUMIRA works in your body.
Your body naturally produces a substance called tumor necrosis factor-alpha (TNF-alpha), which is one of the specific sources of inflammation. Ulcerative colitis (UC) is associated with increased levels of TNF-alpha in the body.
HUMIRA works by targeting and blocking excess TNF-alpha to help reduce inflammation that contributes to UC symptoms, such as abdominal pain and diarrhea.
With HUMIRA, remission is possible.
HUMIRA may help you get your moderate to severe ulcerative colitis (UC) into remission, and sustain remission.
Before making a decision, get the facts.
Discuss Important Safety Information for HUMIRA with your doctor.
Before you and your doctor make a decision about treatment, you should discuss the Important Safety Information for HUMIRA. Talk about any concerns you may have. Working together, you and your doctor can find a treatment that is right for you.
What is the most important information I should know about HUMIRA?
You should discuss the potential benefits and risks of HUMIRA with your doctor. HUMIRA is a tumor necrosis factor (TNF) blocker medicine that can lower the ability of your immune system to fight infections. You should not start taking HUMIRA if you have any kind of infection unless your doctor says it is okay.
- Serious infections have happened in people taking HUMIRA. These serious infections include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body. Some people have died from these infections. Your doctor should test you for TB before starting HUMIRA, and check you closely for signs and symptoms of TB during treatment with HUMIRA, even if your TB test was negative. If your doctor feels you are at risk, you may be treated with medicine for TB.
- Cancer. For children and adults taking TNF blockers, including HUMIRA, the chance of getting lymphoma or other cancers may increase. There have been cases of unusual cancers in children, teenagers, and young adults using TNF blockers. Some people have developed a rare type of cancer called hepatosplenic T-cell lymphoma. This type of cancer often results in death. If using TNF blockers including HUMIRA, your chance of getting two types of skin cancer (basal cell and squamous cell) may increase. These types are generally not life-threatening if treated; tell your doctor if you have a bump or open sore that doesn’t heal.
Learn about the most common side effects of HUMIRA.
Common side effects of HUMIRA include injection site reactions (pain, redness, rash, swelling, itching, or bruising), upper respiratory infections (sinus infections), headaches, rash, and nausea. These are not all of the possible side effects with HUMIRA. Tell your doctor if you have any side effect that bothers you or that does not go away.
It is possible to experience adverse events or side effects from HUMIRA. If you do experience any side effects, call your doctor right away. These are not all of the possible side effects associated with HUMIRA. Click here to see additional Important Safety Information.